Table 2.
Prevalence of pfhrp2 and pfhrp3 deletions including in polyclonal infections in clinical samples.
DNA source | Country |
pfhrp2 and/or pfhrp3 deletions in samples |
pfhrp2/3 deletions in polyclonal infections |
||||
---|---|---|---|---|---|---|---|
pfhrp2 n(%) | pfhrp3 n(%) | pfhp2/3 n%) | pfhrp2 n(%) | pfhrp3 n(%) | pfhp2/3 n(%) | ||
Eritrea | Eritrea (n = 50) | 0 | 10 (20) | 31 (62) | 3 (6) | 4 (8) | 0 |
MRL | Djibouti (n = 1) | 0 | 0 | 0 | 0 | 0 | 0 |
Kenya (n = 20) | 0 | 0 | 0 | 1 (5) | 1 (5) | 0 | |
Eritrea (n = 1) | 0 | 0 | 0 | 0 | 0 | 1 (100) | |
Ethiopia (n = 2) | 0 | 1 (50) | 0 | 0 | 0 | 0 | |
Somalia (n = 3) | 0 | 0 | 0 | 0 | (2) 66.7 | 0 | |
South Sudan (n = 12) | 0 | 3 (25) | 0 | 1 (10) | 0 | 0 | |
Sudan (n = 29) | 1 (3.5) | 1 (3.5) | 1 (3.5) | 0 | 3 (10.3) | 0 | |
Tanzania (n = 16) | 0 | 0 | 0 | 0 | 1 (6.3) | 0 | |
Uganda (n = 27) | 0 | 1 (3.7) | 0 | 2 (7.4) | 3 (11.2) | 0 | |
East Africa (n = 2) | 0 | 0 | 0 | 0 | 0 | 0 | |
Kenya/Tanzania | Kenya (n = 150) | 0 | 0 | 0 | 5 (3.4) | 0 | 0 |
Tanzania (n = 149) | 1 (0.7) | 1 (0.7) | 0 | 1 (0.7) | 0 | 0 |